KTTA
Price
$0.79
Change
-$0.04 (-4.82%)
Updated
Jun 13 closing price
Capitalization
5.85M
TRAW
Price
$1.69
Change
-$0.11 (-6.11%)
Updated
Jun 13 closing price
Capitalization
9.4M
Interact to see
Advertisement

KTTA vs TRAW

Header iconKTTA vs TRAW Comparison
Open Charts KTTA vs TRAWBanner chart's image
Pasithea Therapeutics
Price$0.79
Change-$0.04 (-4.82%)
Volume$291.7K
Capitalization5.85M
Traws Pharma
Price$1.69
Change-$0.11 (-6.11%)
Volume$152.72K
Capitalization9.4M
KTTA vs TRAW Comparison Chart
Loading...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KTTA vs. TRAW commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KTTA is a Hold and TRAW is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (KTTA: $0.79 vs. TRAW: $1.69)
Brand notoriety: KTTA and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KTTA: 3% vs. TRAW: 10%
Market capitalization -- KTTA: $5.85M vs. TRAW: $9.4M
KTTA [@Biotechnology] is valued at $5.85M. TRAW’s [@Biotechnology] market capitalization is $9.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KTTA’s FA Score shows that 1 FA rating(s) are green whileTRAW’s FA Score has 1 green FA rating(s).

  • KTTA’s FA Score: 1 green, 4 red.
  • TRAW’s FA Score: 1 green, 4 red.
According to our system of comparison, TRAW is a better buy in the long-term than KTTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KTTA’s TA Score shows that 4 TA indicator(s) are bullish while TRAW’s TA Score has 5 bullish TA indicator(s).

  • KTTA’s TA Score: 4 bullish, 4 bearish.
  • TRAW’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TRAW is a better buy in the short-term than KTTA.

Price Growth

KTTA (@Biotechnology) experienced а -11.27% price change this week, while TRAW (@Biotechnology) price change was +2.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRAW($9.4M) has a higher market cap than KTTA($5.85M). KTTA YTD gains are higher at: -75.048 vs. TRAW (-80.968). KTTA has higher annual earnings (EBITDA): -13.24M vs. TRAW (-24.89M). TRAW has more cash in the bank: 15.9M vs. KTTA (5.34M). TRAW has higher revenues than KTTA: TRAW (227K) vs KTTA (0).
KTTATRAWKTTA / TRAW
Capitalization5.85M9.4M62%
EBITDA-13.24M-24.89M53%
Gain YTD-75.048-80.96893%
P/E RatioN/AN/A-
Revenue0227K-
Total Cash5.34M15.9M34%
Total Debt0N/A-
FUNDAMENTALS RATINGS
TRAW: Fundamental Ratings
TRAW
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KTTATRAW
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OVBC31.65-0.10
-0.31%
Ohio Valley Banc Corp
ATAT32.30-0.15
-0.46%
Atour Lifestyle Holdings Limited
UHAL62.34-0.96
-1.52%
U-Haul Holding Company
SES0.96-0.04
-3.79%
SES AI Corp
VERB7.10-0.66
-8.51%
Verb Technology Company Inc

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and INCY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and INCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
-5.21%
INCY - KTTA
28%
Poorly correlated
-2.12%
GNFT - KTTA
22%
Poorly correlated
+1.74%
TRAW - KTTA
22%
Poorly correlated
-6.11%
BPMC - KTTA
21%
Poorly correlated
-0.19%
SPRO - KTTA
21%
Poorly correlated
-2.08%
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with SLGL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then SLGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
-6.11%
SLGL - TRAW
47%
Loosely correlated
+8.99%
RAPT - TRAW
46%
Loosely correlated
-4.59%
AVXL - TRAW
35%
Loosely correlated
-2.31%
GTBP - TRAW
30%
Poorly correlated
+0.71%
COCP - TRAW
28%
Poorly correlated
N/A
More